Drug therapy limited in dementia patients

摘要

The benefits of cholinesterase inhibitors and memantine are limited in the treatment of patients with dementia drug therapy, the National Prescribing Services (NPS) said.'Research indicates that the benefits of cholinesterase inhibitors and memantine are small, some people will not respond and adverse effects are common,' said NPS clinical expert, education and quality assurance program manager, Judith Mackson.